Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Celecoxib in Metastatic Androgen Independent Prostate Cancer
NCT00494338Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Nov 2004
- Primary completion
- Apr 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in prostate cancer (PCa), sponsored by Sanofi. Started Nov 2004; status: terminated.
02
Drugs
celecoxib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00494338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494338.